FINWIRES · TerminalLIVE
FINWIRES

Morgan Stanley Lowers Nahdi Medical's PT, Keeps at Overweight

By

Morgan Stanley on Thursday reduced the price target for Saudi Arabian retail pharmacy and healthcare company Nahdi Medical (SASE:4164) to 120 Saudi riyals from 135 riyals and affirmed its overweight rating.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles